FDA Drug Application (021183) for VIDEX EC by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number021183
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
Dosage125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIDEX EC
Active IngredientDIDANOSINE

Active IngredientCount
List of drugs with Active Ingredient DIDANOSINE3


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB